1623 Capital’s Medtronic MDT Stock Holding History

1623 Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-48,000	Closed	-$3.88M	–	35
2022 Q3	$3.88M	Hold	48,000	–	–	2.39%	20
2022 Q2	$4.31M	Hold	48,000	–	–	2.69%	17
2022 Q1	$5.33M	Hold	48,000	–	–	2.67%	17
2021 Q4	$4.97M	Sell	48,000 -6,000	-11%	-$695K	1.85%	25
2021 Q3	$6.77M	Hold	54,000	–	–	2.64%	14
2021 Q2	$6.7M	Hold	54,000	–	–	2.57%	14
2021 Q1	$6.38M	Hold	54,000	–	–	2.61%	16
2020 Q4	$6.33M	Hold	54,000	–	–	3%	14
2020 Q3	$5.61M	Hold	54,000	–	–	2.81%	13
2020 Q2	$4.95M	Buy	54,000 +5,514	+11%	+$529K	3.45%	12
2020 Q1	$4.37M	Buy	48,486 +13,398	+38%	+$1.43M	4.31%	5
2019 Q4	$3.98M	Buy	+35,088	New	+$3.85M	3.8%	15

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

1623 Capital's MDT Position: Q4 2022 in Review

1623 Capital sold out of Medtronic (MDT) in Q4 2022, closing a stake of 48,000 shares — an estimated $3.88M sold.

1623 Capital first reported a position in MDT in Q4 2019 and held it in 12 quarters. The position peaked at $6.77M in Q3 2021. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

1623 Capital reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
1623 Capital sold 48,000 Medtronic shares in Q4 2022, an estimated $3.88M.
1623 Capital first reported a position in Medtronic in Q4 2019 and held it in 12 quarters.
1623 Capital's Medtronic position peaked at $6.77M in Q3 2021.
1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on 1623 Capital's 13F filing for Q4 2022, filed 10 Feb 2023.